IL6 and type 1 diabetes mellitus: Snell-Bergeon, et al.24 (2010) evaluated 553 patients with type 1 diabetes mellitus and 215 healthy patients aged between 10 and 22 years and observed that high levels of IL-6 and other biomarkers were associated with the lipid profile and may collaborate with systemic complications in individuals with diabetes.